STOCK TITAN

[SCHEDULE 13G/A] CONMED Corp Amended Passive Investment Disclosure

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

The Vanguard Group filed an amendment (Schedule 13G/A) reporting zero beneficial ownership of CONMED Corp common stock. The filing states 03/13/2026 and is signed on 03/26/2026. It explains an internal realignment on January 12, 2026 that caused separate reporting by Vanguard subsidiaries and business divisions. The filing lists 0% ownership and 0 shares, and states no single external person holds more than 5% of the class.

Positive

  • None.

Negative

  • None.

Insights

Vanguard reports no beneficial stake in CONMED after internal realignment.

The filing explicitly lists 0 shares and 0% ownership as of 03/13/2026, signed 03/26/2026. It attributes separate reporting to an internal realignment on January 12, 2026 under SEC Release No. 34-39538.

Because the filing shows disaggregation of prior holdings among Vanguard affiliates, subsequent filings from the named subsidiaries may show redistributed positions; current cash‑flow treatment and any subsidiary schedules are not included in this excerpt.






Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: On January 12, 2026, The Vanguard Group, Inc. went through an internal realignment. In accordance with SEC Release No. 34-39538 (January 12, 1998), certain subsidiaries or business divisions of subsidiaries of The Vanguard Group, Inc., that formerly had, or were deemed to have, beneficial ownership with The Vanguard Group, Inc., will report beneficial ownership separately (on a disaggregated basis) from The Vanguard Group, Inc. in reliance on such release. These subsidiaries and/or business divisions pursue the same investment strategies as previously pursued by The Vanguard Group, Inc. prior to the realignment. Further in accordance with SEC Release No. 34-39538 (January 12, 1998), The Vanguard Group, Inc. no longer has, or is deemed to have, beneficial ownership over securities beneficially owned by such subsidiaries and/or business divisions.


SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:03/26/2026
Conmed Corp

NYSE:CNMD

View CNMD Stock Overview

CNMD Rankings

CNMD Latest News

CNMD Latest SEC Filings

CNMD Stock Data

1.13B
30.65M
Medical Devices
Electromedical & Electrotherapeutic Apparatus
Link
United States
LARGO